ETS2 and breast cancer: Upon inhibition of new mRNA transcription with Act D, the ETS2 mRNA degradation rates in UMUC3(shATG7) cells were much more stable than in UMUC3(Nonsense) cells (Figure 7H), suggesting that ATG7 overexpression led to ETS2 mRNA instability in BC cells.